These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27609518)

  • 21. A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
    Kim S; Hahn YK; Podhaizer EM; McLane VD; Zou S; Hauser KF; Knapp PE
    J Neuroinflammation; 2018 Oct; 15(1):285. PubMed ID: 30305110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND.
    Hu G; Liao K; Yang L; Pendyala G; Kook Y; Fox HS; Buch S
    J Neuroimmune Pharmacol; 2017 Sep; 12(3):420-432. PubMed ID: 28236278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocytes mediate HIV-1 Tat-induced neuronal damage via ligand-gated ion channel P2X7R.
    Tewari M; Monika ; Varghse RK; Menon M; Seth P
    J Neurochem; 2015 Feb; 132(4):464-76. PubMed ID: 25272052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice.
    Bruce-Keller AJ; Turchan-Cholewo J; Smart EJ; Geurin T; Chauhan A; Reid R; Xu R; Nath A; Knapp PE; Hauser KF
    Glia; 2008 Oct; 56(13):1414-27. PubMed ID: 18551626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.
    Rahimian P; He JJ
    J Neurovirol; 2016 Dec; 22(6):774-788. PubMed ID: 27173397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine upregulates SIRT3 expression to ameliorate astrocytes-mediated HIV-1 Tat neurotoxicity via suppression of EGR1 signaling pathway.
    Gao L; Sun W; Zhang L; Liang C; Zhang D
    J Neurovirol; 2024 Jun; 30(3):286-302. PubMed ID: 38926255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV Tat Impairs Neurogenesis through Functioning As a Notch Ligand and Activation of Notch Signaling Pathway.
    Fan Y; Gao X; Chen J; Liu Y; He JJ
    J Neurosci; 2016 Nov; 36(44):11362-11373. PubMed ID: 27807176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.
    Asensio VC; Maier J; Milner R; Boztug K; Kincaid C; Moulard M; Phillipson C; Lindsley K; Krucker T; Fox HS; Campbell IL
    J Virol; 2001 Aug; 75(15):7067-77. PubMed ID: 11435587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.
    Paris JJ; Singh HD; Carey AN; McLaughlin JP
    Behav Brain Res; 2015 Sep; 291():209-218. PubMed ID: 26005128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomics analysis of human astrocytes expressing the HIV protein Tat.
    Pocernich CB; Boyd-Kimball D; Poon HF; Thongboonkerd V; Lynn BC; Klein JB; Calebrese V; Nath A; Butterfield DA
    Brain Res Mol Brain Res; 2005 Feb; 133(2):307-16. PubMed ID: 15710248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.
    Nookala AR; Kumar A
    J Neuroinflammation; 2014 Dec; 11():214. PubMed ID: 25539898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astrocytic metabolic switch is a novel etiology for Cocaine and HIV-1 Tat-mediated neurotoxicity.
    Natarajaseenivasan K; Cotto B; Shanmughapriya S; Lombardi AA; Datta PK; Madesh M; Elrod JW; Khalili K; Langford D
    Cell Death Dis; 2018 Apr; 9(4):415. PubMed ID: 29549313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration.
    Fields JA; Metcalf J; Overk C; Adame A; Spencer B; Wrasidlo W; Florio J; Rockenstein E; He JJ; Masliah E
    J Neurovirol; 2017 Apr; 23(2):290-303. PubMed ID: 28105557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of astrocyte activation by TAT-mediated delivery of a peptide JNK inhibitor.
    Kang WH; Simon MJ; Gao S; Banta S; Morrison B
    J Neurotrauma; 2011 Jul; 28(7):1219-28. PubMed ID: 21510821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel role of mortalin in attenuating HIV-1 Tat-mediated astrogliosis.
    Priyanka ; Wadhwa R; Chaudhuri R; Nag TC; Seth P
    J Neuroinflammation; 2020 Sep; 17(1):276. PubMed ID: 32951595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein.
    Kim BO; Liu Y; Zhou BY; He JJ
    J Immunol; 2004 Feb; 172(3):1888-95. PubMed ID: 14734774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
    Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K
    J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice.
    Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M
    J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Tat-induced bystander apoptosis in Jurkat cells involves unfolded protein responses.
    Campestrini J; Silveira DB; Pinto AR
    Cell Biochem Funct; 2018 Oct; 36(7):377-386. PubMed ID: 30246458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocaine and HIV-1 Tat disrupt cholesterol homeostasis in astrocytes: Implications for HIV-associated neurocognitive disorders in cocaine user patients.
    Cotto B; Natarajaseenivasan K; Ferrero K; Wesley L; Sayre M; Langford D
    Glia; 2018 Apr; 66(4):889-902. PubMed ID: 29330881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.